Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2004-5-11
pubmed:abstractText
At the Emma Kinderziekenhuis/Academic Medical Center in Amsterdam, survivors of childhood cancer are screened annually or biennially for the occurrence of late treatment effects. The screening procedures are based on previously used treatment modalities. The data gathered at the outpatient clinic are registered in the database PLEKsys. Evaluation of the data concerning over 1000 cancer survivors screened since the start of the clinic once more illustrated the relation between cranial irradiation and the development of central endocrine abnormalities. Surprisingly, at least a proportion of the growth hormone (GH)-deficient cancer survivors were registered as not being on a replacement therapy regimen. The reasons for survivors not to be on replacement therapy are currently being evaluated. The late-effects outpatient clinic and the PLEKsys database provide a platform for additional research in fields including endocrinology, which should be aimed at improving the care for and the health status of the survivors of childhood cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1096-6374
pubmed:author
pubmed:issnType
Print
pubmed:volume
14 Suppl A
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S125-8
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Screening for late effects in survivors of childhood cancer: growth hormone deficiency from a pediatric oncologist's point of view.
pubmed:affiliation
Polikliniek Late Effecten Kindertumoren (PLEK) and Late Effects Study Group Emma Kinderziekenhuis/Academic Medical Center, Amsterdam, The Netherlands. c.vandenbos@amc.uva.nl
pubmed:publicationType
Journal Article, Review